Nasodine and the Nipah outbreak

@@MADX reported in another thread on the current publicity around the Nipah virus outbreak in Southeast Asia (https://bit.ly/49LsMi4). Shareholders have also contacted by phone and email on the same topic. This serious and rapidly evolving situation is worthy of its own thread, which I have started here.
Fortunately and unlike during COVID, Nasodine is now available to help.

This Nipah Virus outbreak was first brought to my attention 3 days ago by our licensing partner in Singapore (Innorini), who reported enhanced screening in Singapore for all visitors from India and Malaysia. Innorini wanted to know what role Nasodine could play. Here's my response to Innorini with some minor amends:

Nipah virus (NiV) is an enveloped virus like coronavirus, influenza, HMPV and RSV. In fact all the nasty, pandemic-potential viruses are enveloped. The good news is that enveloped viruses are the most sensitive to povidone-iodine (Nasodine) and there is no scientific basis to think that NiV would be any different.
In the case of NiV, it’s not a virus that causes the common cold, so we never tried to test it against Nasodine, but from a practical perspective, it's a BSL4 (Biosafety Level 4) pathogen, so like Ebola it's very hard to do any inactivation studies on it. However, it is a member of the paramyxovirus family and we have kill time data that show that Nasodine 100% inactivates its cold-causing paramyxovirus cousin, parainfluenza virus, within 60 seconds of contact. Same with flu, RSV and HMPV.
Could Nasodine help protect people from transmission risk? I would definitely use it as an added protection. Here’s why.NiV is zoonotic, i.e., transmitted from animals to humans, like bird flu and Ebola. For NiV, the primary source is fruit bats, with pigs are the main intermediary species that pass it on to humans.According to WHO, “consumption of fruits or fruit products (such as raw date palm juice) contaminated with urine or saliva from infected fruit bats was the most likely source of infection.”
However, also according to WHO (https://bit.ly/4a4cH5X), human-to-human transmission can occur and “has also been reported among family and care givers of infected patients.” This is because it can cause respiratory symptoms, as we know from colds and flu, that’s the fastest way to spread viruses between people. Again according to WHO (https://www.who.int/news-room/fact-sheets/detail/nipah-virus), “Evidence from outbreak investigations indicates that transmission risk is highest when patients have prominent respiratory disease and high-contact caregiving, consistent with virus in respiratory secretions and severe pulmonary involvement in many outbreaks.”
Given the fatality rate is 40% to 75% of infected people, that it can be transmitted by someone with respiratory symptoms, and that Nasodine kills all viruses, I would not hesitate to recommend using Nasodine Nasal Spray and Nasodine Throat Spray, in addition to PPE and other precautions for any frontline HCWs.

Innorini is now approaching hospitals and government authorities in Singapore to explore how Nasodine can be deployed to help. They are also exploring the potential to see Nasodine rapidly deployed in other countries in AE Asia.

I'll keep you posted as we learn more.

Peter M